ESC 365 - Risk stratification of stable coronary artery disease in patients with comorbidities

ESC Premium Access

Risk stratification of stable coronary artery disease in patients with comorbidities

Event: ESC CONGRESS 2016

Topic: CAD and comorbidities

Session type: Advances in Science

Date: 28 August 2016

Time: 11:00 - 12:30

Session

4 presentations in this session

State of the art in risk stratification of stable CAD in patients with comorbidities.

Speaker: Professor C. Vrints (Antwerp, BE)

Serial high sensitivity troponin I and long-term outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial

Speaker: Associate Professor P. Jarolim (Boston, US)

Comparison of three chronic kidney disease epidemiology collaboration (CKD-EPI) equations for prediction of coronary plaque vulnerability: an optical coherence tomography study

Speaker: Doctor D. Jiannan (Harbin, CN)

Future direction for research in risk stratification of stable CAD in patients with comorbidities.

Speaker: Doctor M. Di Carli (Boston, US)

4 speakers from this session

Professor Christiaan Jm Vrints

University of Antwerp, Antwerp (Belgium)

17 presentations

0 follower

Associate Professor Petr Jarolim

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

Doctor Dai Jiannan

The 2nd Affiliated Hospital of Harbin Medical University, Harbin (China)

0 follower

Doctor Marcelo Fernando Di Carli

Brigham and Women's Hospital, Boston (United States of America)

4 presentations

0 follower

This platform is supported by